Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer: early-phase trial registry
279 of 621 indexed Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #6 of 28,963 conditions by registered trial count.
621 US clinical trials · 279 currently recruiting · #6 of 28,963 conditions by registered trial count
Cancer: 621 US clinical trials tracked, 279 recruiting.
Cancer is the subject of 621 registered US clinical trials on ClinicalTrials.gov, 279 of them currently open to new participants. 31 are in Phase 3-4 (later-stage) and 164 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 31 of these trials.
Open enrollment, early-phase tilt
Cancer has 621 registered US clinical trials, 279 of them open to new participants right now, about 45% of the total.
- 279
- recruiting participants now
- 45%
- of trials open to enrollment
- 31
- in Phase 3-4 (later-stage)
- 31
- top sponsor: M.D. Anderson Cancer Center
Corpus placement: #6 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Cancer on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer is recruiting above its size-band peers.
279 of 621 indexed trials (44.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 31 of 621 trials (5%). 270 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer enrolment sits around 108 participants.
Median target enrolment is 108 among the 616 trials that report a genuine target (sentinel values excluded). 287 of those (46.6%) plan for fewer than 100 participants.
-
Cancer research is mostly interventional.
462 interventional and 159 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
621 total, page 7 of 13
9-ING-41 in Patients with Advanced Cancers
Actuate Therapeutics
NCT03678883
Nurse AMIE (Addressing Malignancies in Individuals Everyday)
University of Pittsburgh
NCT05221606
Onco-primary Care Networking to Support TEAM-based Care
Duke University
NCT04258813
Optimization of a mHealth Physical Activity Promotion Intervention With Mindful Awareness for AYAO (OPT2MOVE)
Northwestern University
NCT05375162
Construal Level as a Novel Pathway for Affect Regulation and Cancer Control
University of Oregon
NCT04620915
Adolescent and Young Adult Cancer Survivors: Identity Development
Memorial Sloan Kettering Cancer Center
NCT00832325
Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy
Lyvgen Biopharma Holdings Limited
NCT04130542
Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial Trial
University of Alabama at Birmingham
NCT04803604
Guaranteed Income and Financial Treatment
Meredith Doherty, PhD, LCSW
NCT06611982
Surgery for Cancer With Option of Palliative Care Expert
Vanderbilt University Medical Center
NCT03436290
Using Information Technology to Improve Outcomes for Children Living With Cancer
Northwestern University
NCT04789720
Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care
Abramson Cancer Center at Penn Medicine
NCT05331625
SMLI With Hispanic Cancer Survivors and Caregivers
University of Arizona
NCT05364372
EMPOWER 3: Improving Palliative Care Health Literacy and Utilization
Tulane University
NCT04733469
Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer
M.D. Anderson Cancer Center
NCT05763797
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
AbbVie
NCT03844048
Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
Masonic Cancer Center, University of Minnesota
NCT05665543
Improving Outcomes for Older Adults Undergoing Radiation Therapy
Icahn School of Medicine at Mount Sinai
NCT05721053
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
AbbVie
NCT03893955
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
ENB Therapeutics
NCT04205227
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Loren Mell, MD
NCT03383094
Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Lyvgen Biopharma Holdings Limited
NCT04635995
A Study of a Telemedicine Program for Older Adults With Cancer
Memorial Sloan Kettering Cancer Center
NCT04917848
IGNITE Firefighters' Health
Stanford University
NCT06567561
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Aadi Bioscience
NCT05103358
DASH INtervention to INvestigate the Gut
H. Lee Moffitt Cancer Center and Research Institute
NCT04538482
Cancer Survivor Cardiomyopathy Detection
Mayo Clinic
NCT05201014
Supportive Oncology Care at Home Post-Discharge
Massachusetts General Hospital
NCT04637035
Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers
City of Hope Medical Center
NCT02041416
Ovarian Tissue Cryopreservation in Children
Mayo Clinic
NCT02646384
The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study
M.D. Anderson Cancer Center
NCT05836857
Addressing Financial and Social Needs Among Patients With Cancer
University of California, Irvine
NCT06430840
Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients
Cedars-Sinai Medical Center
NCT03757182
Decreasing Polypharmacy in Older Adults With Curable Cancers Trial
University of Rochester
NCT05046171
Motivational Interviewing for Physical Activity
M.D. Anderson Cancer Center
NCT01008787
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
Massachusetts General Hospital
NCT03768336
Electroacupuncture for the Management of Symptom Clusters in Cancer Patients and Survivors
University of California, Irvine
NCT05283577
Biomarkers of Immune-Related Toxicity
University of Colorado, Denver
NCT03409016
Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors
Memorial Sloan Kettering Cancer Center
NCT04916249
An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer
AbbVie
NCT04189614
Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication
Dana-Farber Cancer Institute
NCT07147023
AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
AstraZeneca
NCT00463814
Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry
University of California, San Diego
NCT01843140
A Study of TAVO412 in Patients with Cancer
Tavotek Biotherapeutics
NCT05548634
Opiophobia in Adults With Advanced Cancer
M.D. Anderson Cancer Center
NCT07093567
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
Joaquina Baranda
NCT03560882
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics
NCT04660929
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Emory University
NCT02574728
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
HUYABIO International
NCT05485974
Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer
St. Jude Children's Research Hospital
NCT05550948
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 116 |
| Phase 2 | 48 |
| Phase 3 | 27 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Cancer right now
279 recruiting of 621 indexed (45% open).
Phase mix: 31 late (III/IV) vs 164 early (I/II) (early-phase heavy).
Top sponsor: M.D. Anderson Cancer Center (31 trials), 9 others listed. 50 shown below, recruiting first. #6 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Cancer?
PlainTrial tracks 621 US clinical trials for Cancer, of which 279 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Cancer?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.